MedTrace Logo

Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury

NCT02891941 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-09-08

No results posted yet for this study

Summary

This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumatic brain injury (MTBI).

Conditions

Sponsors & Collaborators

Principal Investigators

  • Vani Rao, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-01-31
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891941 on ClinicalTrials.gov